Grant of Options and PDMR dealing
Feedback plc has granted 438,148 options to its Chief Financial Officer, Emma Oswick, under its EMI Share Option Scheme, exercisable at 20 pence per share, which represents a 105% premium to the previous day's closing price. These options vest in four equal tranches, with 25% vesting annually over three years and the remaining 75% contingent on achieving reported revenue targets of £8 million, £12 million, and £20 million. Following this grant, Emma Oswick will hold options representing 1.0% of the company's existing issued share capital, and the total outstanding options will represent 10.2% of the issued share capital.
Select text to share a quote on X · sign in to keep highlights & notes in your FDBK notes
Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, announces that it has granted a total of 438,148 options to subscribe for new ordinary shares of 1 penny each in the Company ("Ordinary Shares") under the Company's EMI Share Option Scheme (the "Options") to Emma Oswick, Chief Financial Officer as detailed below.
The Options are being issued to appropriately incentivise management, as well as to ensure their interests are aligned with that of the Company and its Shareholders. The Options are exercisable at 20 pence per share. This price reflect the price at which the Company last completed an equity fundraise in November 2024 and represents a premium of 105% per cent to the closing share price on the last trading day before this announcement.
The Options will vest in four equal tranches as follows:
- 25% vest in three equal sub-tranches annually (8.33% on each of the first, second and third anniversary of grant of 22nd April 2026)
- 25% vest on reported revenue of £8m
- 25% vest on reported revenue of £12m; and
- 25% vest on reported revenue of £20m
"Reported Revenue" is either:
- a year's revenue reported in the full year audited financial statements; or
- 12 months' revenue being H2 of the last full year audited financial statements plus H1 of the last published interim financial statements.
The Options are exercisable for a period of 5 years from the vesting date.
Following the grant of Options, Emma Oswick will hold a total interest in the Company of 438,148 options. The Options represent in aggregate 1.0% of the Company's existing issued share capital.
Following the grant of the Options and taking into account existing options, the Company has a total of 4,481,061 options to subscribe for ordinary shares in the Company in issue, representing 10.2% of the Company's issued share capital at the date of this announcement.
Further information on Feedback and its products can be found on the Company's website: https://feedbackmedical.com
Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities under UK MAR
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Emma Oswick |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR - Chief Financial Officer |
| b) | Initial notification /Amendment | Initial |
| a) | Name | Feedback plc |
| b) | LEI | 213800UGOF2GT2U2RV90 |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 1 penny each GB00BJN59X09 |
| b) | Nature of the transaction | Grant of options to subscribe for Ordinary Shares |
| c) | Price(s) and volume(s) | Price(s) Volume(s) Nil 438,148 |
| d) | Aggregated information - Aggregated volume - Price | N/A |
| e) | Date of the transaction | 22 nd April 2026 |
| f) | Place of the transaction | Outside a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.